UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.514

Sortiert nach

HDR Prostate Brachytherapy

Seminars in radiation oncology, 2020-01, Vol.30 (1), p.49-60

2020

Volltextzugriff (PDF)

Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer

Radiotherapy and oncology, 2023-03, Vol.180, p.109495, Article 109495

2023

Volltextzugriff (PDF)

Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients

Radiotherapy and oncology, 2019-12, Vol.141, p.149-155

2019

Volltextzugriff (PDF)

Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life

Radiotherapy and oncology, 2020-08, Vol.149, p.240-245

2020

Volltextzugriff (PDF)

Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes

American journal of clinical oncology, 2021-04, Vol.44 (4), p.131

2021

Volltextzugriff (PDF)

Compendium of fractionation choices for gynecologic HDR brachytherapy—An American Brachytherapy Society Task Group Report

Brachytherapy, 2019-07, Vol.18 (4), p.429-436

2019

Volltextzugriff (PDF)

Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer

Radiotherapy and oncology, 2023-09, Vol.186, p.109807-109807, Article 109807

2023

Volltextzugriff (PDF)

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Clinical cancer research, 2022-09, Vol.28 (17), p.3742-3751

2022

Volltextzugriff (PDF)

Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT

International journal of radiation oncology, biology, physics, 2020-02, Vol.106 (2), p.291-299

2020

Volltextzugriff (PDF)

Salvage HDR Brachytherapy for Recurrent Prostate Cancer After Previous Definitive Radiation Therapy: 5-Year Outcomes

International journal of radiation oncology, biology, physics, 2013-06, Vol.86 (2), p.324-329

2013

Volltextzugriff (PDF)

Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial

Radiotherapy and oncology, 2020-05, Vol.146, p.16-20

2020

Volltextzugriff (PDF)

Salvage HDR Brachytherapy: Multiple Hypothesis Testing Versus Machine Learning Analysis

International journal of radiation oncology, biology, physics, 2018-07, Vol.101 (3), p.694-703

2018

Volltextzugriff (PDF)

MRI-Guided Ultrafocal HDR Brachytherapy for Localized Prostate Cancer: Median 4-Year Results of a feasibility study

International journal of radiation oncology, biology, physics, 2019-08, Vol.104 (5), p.1045-1053

2019

Volltextzugriff (PDF)

Feasibility of improving patient’s safety with in vivo dose tracking in intracavitary and interstitial HDR brachytherapy

Brachytherapy, 2021-03, Vol.20 (2), p.353-360

2021

Volltextzugriff (PDF)

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

Frontiers in oncology, 2022-07, Vol.12, p.935310-935310

2022

Volltextzugriff (PDF)

A multicentre ‘end to end’ dosimetry audit for cervix HDR brachytherapy treatment

Radiotherapy and oncology, 2015-02, Vol.114 (2), p.264-271

2015

Volltextzugriff (PDF)

Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis

Strahlentherapie und Onkologie, 2023-02, Vol.199 (2), p.141-148

2023

Volltextzugriff (PDF)

GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level

Radiotherapy and oncology, 2022-11, Vol.176, p.108-117

2022

Volltextzugriff (PDF)

MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life

Radiotherapy and oncology, 2018-12, Vol.129 (3), p.554-560

2018

Volltextzugriff (PDF)

HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study

Radiotherapy and oncology, 2013-11, Vol.109 (2), p.194-199

2013

Volltextzugriff (PDF)

Fast and fully-automated multi-criterial treatment planning for adaptive HDR brachytherapy for locally advanced cervical cancer

Radiotherapy and oncology, 2020-07, Vol.148, p.143-150

2020

Volltextzugriff (PDF)

Inversion-recovery ultrashort-echo-time (IR-UTE) MRI-based detection of radiation dose heterogeneity in gynecologic cancer patients treated with HDR brachytherapy

Radiation oncology (London, England), 2024-08, Vol.19 (1), p.105-10, Article 105

2024

Volltextzugriff (PDF)

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

Radiation oncology (London, England), 2022-12, Vol.17 (1), p.203-203, Article 203

2022

Volltextzugriff (PDF)

21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot study

Brachytherapy, 2024-05, Vol.23 (3), p.321-328

2024

Volltextzugriff (PDF)

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Radiotherapy and oncology, 2022-04, Vol.169, p.51-56

2022

Volltextzugriff (PDF)

1 – 25 von 5.514

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

Zeitschrift / SerieBusiness Wire

Zeitschrift / SerieJournal Of Contemporary Brachytherapy

SpracheTürkisch

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.692)
Mit Volltextzugriff
(4.704)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.691)
Life Sciences & Biomedicine
(4.648)
Humans
(3.299)
Radiology, Nuclear Medicine & Medical Imaging
(2.412)
Female
(1.885)
Brachytherapy
(1.687)
Middle Aged
(1.529)
Brachytherapy - Methods
(1.528)
Aged
(1.473)
Radiotherapy Dosage
(1.399)
Male
(1.332)
Hematology, Oncology And Palliative Medicine
(1.218)
Radiation Therapy
(1.209)
Radiotherapy
(1.058)
Adult
(1.012)
Radiology
(938)
Medicine
(879)
Patients
(777)
Aged, 80 And Over
(775)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

HDR Prostate Brachytherapy

Recurrence characteristics after focal salvage HDR brachytherapy in prostate cancer

Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients

Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life

Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes

Compendium of fractionation choices for gynecologic HDR brachytherapy—An American Brachytherapy Society Task Group Report

Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT

Salvage HDR Brachytherapy for Recurrent Prostate Cancer After Previous Definitive Radiation Therapy: 5-Year Outcomes

Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial

Salvage HDR Brachytherapy: Multiple Hypothesis Testing Versus Machine Learning Analysis

MRI-Guided Ultrafocal HDR Brachytherapy for Localized Prostate Cancer: Median 4-Year Results of a feasibility study

Feasibility of improving patient’s safety with in vivo dose tracking in intracavitary and interstitial HDR brachytherapy

High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial

A multicentre ‘end to end’ dosimetry audit for cervix HDR brachytherapy treatment

Outcome analysis of HDR compared to PDR IGABT in locally advanced cervical cancer: a single-center cohort analysis

GEC-ESTRO ACROP recommendations on calibration and traceability of HE HDR-PDR photon-emitting brachytherapy sources at the hospital level

MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life

HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study

Fast and fully-automated multi-criterial treatment planning for adaptive HDR brachytherapy for locally advanced cervical cancer

Inversion-recovery ultrashort-echo-time (IR-UTE) MRI-based detection of radiation dose heterogeneity in gynecologic cancer patients treated with HDR brachytherapy

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot study

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Aktive Filter

Suchergebnisse filtern